Median time to pain improvement and the impact of baseline pain severity on pain response in patients with psoriatic arthritis treated with tofacitinib
<br><strong>Background </strong>Pain is a core domain of psoriatic arthritis (PsA). This post hoc analysis evaluated time to pain improvement and the impact of baseline pain severity on pain response in patients with PsA receiving tofacitinib. <br><strong> Methods </...
Հիմնական հեղինակներ: | de Vlam, K, Ogdie, A, Bushmakin, AG, Cappelleri, JC, Fleischmann, R, Taylor, PC, Azevedo, V, Fallon, L, Woolcott, J, Mease, PJ |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
BMJ Publishing Group
2021
|
Նմանատիպ նյութեր
-
Median time to pain improvement in patients with psoriatic arthritis treated with tofacitinib
: de Vlam, K, և այլն
Հրապարակվել է: (2018) -
Baseline pain severity as a predictor of pain improvement following treatment with tofacitinib in psoriatic arthritis
: Ogdie, A, և այլն
Հրապարակվել է: (2018) -
Identifying and quantifying the role of inflammation in pain reduction for patients with psoriatic arthritis treated with tofacitinib: a mediation analysis
: de Vlam, K, և այլն
Հրապարակվել է: (2022) -
Understanding mediators of pain reduction in psoriatic arthritis patients treated with tofacitinib: role of inflammation
: Taylor, P, և այլն
Հրապարակվել է: (2019) -
Identifying mediators of pain reduction in patients with psoriatic arthritis treated with tofacitinib: Role of inflammation associated with peripheral arthritis, enthesitis and skin disease
: Taylor, PC, և այլն
Հրապարակվել է: (2020)